11/14/2024
3:33 PM | ArriVent BioPharma (Subject)
HHLR ADVISORS, LTD. (Filed by)
| Form SC 13G | |
11/14/2024
7:00 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:01 AM | ArriVent BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
1:45 PM | ArriVent BioPharma (Subject)
Sofinnova Venture Partners XI, L.P. (Filed by)
| Form SC 13G | |
10/24/2024
1:02 PM | ArriVent BioPharma (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
09/23/2024
5:14 PM | ArriVent BioPharma (Issuer)
LaChapelle Robin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
11:15 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
07/09/2024
4:03 PM | ArriVent BioPharma (Filer)
| Form 8-K/A | |
07/09/2024
4:05 PM | ArriVent BioPharma (Filer)
| Form 8-K/A | |
06/05/2024
6:15 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
4:29 PM | ArriVent BioPharma (Issuer)
Hohneker John (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/20/2024
4:30 PM | ArriVent BioPharma (Issuer)
Hohneker John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
7:00 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
7:01 AM | ArriVent BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2024
3:05 PM | ArriVent BioPharma (Issuer)
Peterson Kristine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/23/2024
3:06 PM | ArriVent BioPharma (Issuer)
Peterson Kristine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
3:10 PM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2024
3:42 PM | ArriVent BioPharma (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D | |
02/01/2024
3:47 PM | ArriVent BioPharma (Issuer)
HHLR ADVISORS, LTD. (Reporting)
HILLHOUSE INVESTMENT MANAGEMENT, LTD. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:10 PM | ArriVent BioPharma (Issuer)
HEALY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:11 PM | ArriVent BioPharma (Issuer)
GORDON CARL L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:12 PM | ArriVent BioPharma (Issuer)
OrbiMed Advisors IV Ltd (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Asia GP IV, L.P. (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:05 PM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
11:15 PM | ArriVent BioPharma (Filer)
| Form EFFECT | |
01/25/2024
8:01 PM | ArriVent BioPharma (Issuer)
HILLHOUSE INVESTMENT MANAGEMENT, LTD. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:36 PM | ArriVent BioPharma (Issuer)
Jallal Bahija (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:36 PM | ArriVent BioPharma (Issuer)
GORDON CARL L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:37 PM | ArriVent BioPharma (Issuer)
HEALY JAMES (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:38 PM | ArriVent BioPharma (Issuer)
Kastenmayer James Paul (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:38 PM | ArriVent BioPharma (Issuer)
Kung Winston (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:38 PM | ArriVent BioPharma (Issuer)
LaChapelle Robin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:39 PM | ArriVent BioPharma (Issuer)
Lutzker Stuart (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:39 PM | ArriVent BioPharma (Issuer)
Nolet Chris (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:39 PM | ArriVent BioPharma (Issuer)
Yao Zhengbin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:40 PM | ArriVent BioPharma (Issuer)
OrbiMed Advisors IV Ltd (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Asia GP IV, L.P. (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
6:37 PM | ArriVent BioPharma (Filer)
| Form S-1MEF | |
01/25/2024
11:32 AM | ArriVent BioPharma (Filer)
| Form CERT | |
01/23/2024
4:18 PM | ArriVent BioPharma (Filer)
| Form S-1/A | |
01/23/2024
3:08 PM | ArriVent BioPharma (Filer)
| Form 8-A12B | |
01/22/2024
5:35 AM | ArriVent BioPharma (Filer)
| Form S-1/A | |
01/05/2024
3:16 PM | ArriVent BioPharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad) One tiny company...
Could quickly become "the next SpaceX."
It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00.
Get urgent details inside this free report... The Next SpaceX Pre-IPO |
